


Healthcare Industry NewsFeed
HSMN NewsFeed - 12 Mar 2021
Cardinal Health Signs Definitive Agreement to Sell its Cordis Business to Hellman & Friedman
Cardinal Health Signs Definitive Agreement to Sell its Cordis Business to Hellman & Friedman
HSMN NewsFeed - 11 Mar 2021
Qardio Announces FDA Clearance for QardioCore, a self-fit continuous ambulatory ECG to view and annotate ECG
Qardio Announces FDA Clearance for QardioCore, a self-fit continuous ambulatory ECG to view and annotate ECG
HSMN NewsFeed - 11 Mar 2021
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
HSMN NewsFeed - 10 Mar 2021
Novum Medical(TM) Appoints Tom Afzal as CEO and Announces Closing of Financing
Novum Medical(TM) Appoints Tom Afzal as CEO and Announces Closing of Financing
HSMN NewsFeed - 10 Mar 2021
Subtle Medical Launches SubtleMR(TM) 2.0 to Expand Improved MRI Capabilities
Subtle Medical Launches SubtleMR(TM) 2.0 to Expand Improved MRI Capabilities
HSMN NewsFeed - 10 Mar 2021
Hollister Incorporated Launches Infyna Chic(TM) Intermittent Catheter in the US
Hollister Incorporated Launches Infyna Chic(TM) Intermittent Catheter in the US
HSMN NewsFeed - 10 Mar 2021
Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization
Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization
HSMN NewsFeed - 9 Mar 2021
Lilly Announces Leadership Transitions in Manufacturing and Ethics and Compliance Organizations
Lilly Announces Leadership Transitions in Manufacturing and Ethics and Compliance Organizations
HSMN NewsFeed - 8 Mar 2021
Solta Medical Announces the U.S. Launch of The Clear + Brilliant(R) Touch Laser
Solta Medical Announces the U.S. Launch of The Clear + Brilliant(R) Touch Laser
HSMN NewsFeed - 5 Mar 2021
Elekta and IBA strengthen partnership to help cancer centers integrate proton therapy
Elekta and IBA strengthen partnership to help cancer centers integrate proton therapy
HSMN NewsFeed - 3 Mar 2021
Creative Medical Technology Holdings Provides Update on ImmCelz(R) FDA Application
Creative Medical Technology Holdings Provides Update on ImmCelz(R) FDA Application
HSMN NewsFeed - 1 Mar 2021
Perrigo Announces Agreement To Sell Generic Rx Business For $1.55 Billion In Total Consideration
Perrigo Announces Agreement To Sell Generic Rx Business For $1.55 Billion In Total Consideration
